[Neurologic and psychic complications in treatment with neuroleptics]

Improved method for MR microscopy of brain tissue cultured with the interface method combined with Lenz lenses.

Magnetic resonance imaging·2018

Hypersensitivity pneumonitis and antigen identification--An alternate approach.

Respiratory medicine·2016

Principles of practice from the European expert panel on the contemporary treatment of schizophrenia.

International journal of psychiatry in clinical practice·2014

Effect of chronic treatment with NNC 756, a new D-1 receptor antagonist, or raclopride, a D-2 receptor antagonist, in drug-naive Cebus monkeys: dystonia, dyskinesia and D-1/D-2 supersensitivity.

Journal of psychopharmacology (Oxford, England)·2012

Extracellular serine proteases from Stenotrophomonas maltophilia: Screening, isolation and heterologous expression in E. coli.

Journal of biotechnology·2011

Topoisomerase II levels and drug response in small cell lung cancer.

International journal of oncology·2011

[Suture lateralisation of the vocal fold in a patient with bilateral vocal cord paralysis].

Ugeskrift for laeger·2026

[Nontoxigenic Vibrio cholerae O1 bacteraemia and cholangitis in a returning traveller from Sri Lanka].

Ugeskrift for laeger·2026

[Transcranial magnetic stimulation in non-psychiatric disorders].

Ugeskrift for laeger·2026

[Coronary artery calcium and cardiovascular prevention].

Ugeskrift for laeger·2026

[Advanced therapy medicinal products].

Ugeskrift for laeger·2026

[Giant panniculectomy].

Ugeskrift for laeger·2026

Concealed cardiomyopathy in sudden childhood death: translation from molecular autopsy to family assessment.

European journal of human genetics : EJHG·2026

Gain-of-function suppressors restore microtubule dynamics and rescue dominant-negative tubulinopathies.

Nature cell biology·2026

[4-Repeat Tauopathies: Progressive Supranuclear Palsy and Corticobasal Degeneration].

Fortschritte der Neurologie-Psychiatrie·2026

Neurofibromatosis 1 (NF1) gene testing reveals rising variant allele fraction as an early warning sign of juvenile myelomonocytic leukemia.

European journal of medical genetics·2026

Midbrain organoids as next-generation models for Parkinson's disease: From pathogenesis to therapeutic discovery.

Experimental neurology·2026

Selective Neuroprotection in the ALS-FTD Spectrum: Mechanisms of Neuronal Resilience and Translational Perspectives.

Brain research bulletin·2026

Related Experiment Videos

[Neurologic and psychic complications in treatment with neuroleptics]

Related Concept Videos

Improved method for MR microscopy of brain tissue cultured with the interface method combined with Lenz lenses.

Hypersensitivity pneumonitis and antigen identification--An alternate approach.

Principles of practice from the European expert panel on the contemporary treatment of schizophrenia.

Effect of chronic treatment with NNC 756, a new D-1 receptor antagonist, or raclopride, a D-2 receptor antagonist, in drug-naive Cebus monkeys: dystonia, dyskinesia and D-1/D-2 supersensitivity.

Extracellular serine proteases from Stenotrophomonas maltophilia: Screening, isolation and heterologous expression in E. coli.

Topoisomerase II levels and drug response in small cell lung cancer.

[Suture lateralisation of the vocal fold in a patient with bilateral vocal cord paralysis].

[Nontoxigenic Vibrio cholerae O1 bacteraemia and cholangitis in a returning traveller from Sri Lanka].

[Transcranial magnetic stimulation in non-psychiatric disorders].

[Coronary artery calcium and cardiovascular prevention].

[Advanced therapy medicinal products].

[Giant panniculectomy].

Concealed cardiomyopathy in sudden childhood death: translation from molecular autopsy to family assessment.

Gain-of-function suppressors restore microtubule dynamics and rescue dominant-negative tubulinopathies.

[4-Repeat Tauopathies: Progressive Supranuclear Palsy and Corticobasal Degeneration].

Neurofibromatosis 1 (NF1) gene testing reveals rising variant allele fraction as an early warning sign of juvenile myelomonocytic leukemia.

Midbrain organoids as next-generation models for Parkinson's disease: From pathogenesis to therapeutic discovery.

Selective Neuroprotection in the ALS-FTD Spectrum: Mechanisms of Neuronal Resilience and Translational Perspectives.

Related Experiment Videos

[Neurologic and psychic complications in treatment with neuroleptics]

Related Concept Videos

Related Articles